Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Expression monitoring by hybridization to high-density oligonucleotide arrays
1996 • 2,796 citations
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
1993 • 2,360 citations
SYFPEITHI: database for MHC ligands and peptide motifs
1999 • 2,307 citations
Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project
1991 • 2,286 citations
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
1994 • 1,553 citations
MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
1994 • 1,448 citations
Genome-wide expression monitoring in Saccharomyces cerevisiae
1997 • 990 citations
New Goals for the U.S. Human Genome Project: 1998-2003
1998 • 848 citations
Sequence identification of 2,375 human brain genes
1992 • 764 citations
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells
1989 • 706 citations
Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
1998 • 611 citations
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
1995 • 583 citations
Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
1998 • 514 citations
Promiscuous and allele-specific anchors in HLA-DR-binding peptides
1993 • 383 citations
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
1987 • 367 citations
X-Ray Crystal Structure of HLA-DR4 (DRA*0101, DRB1*0401) Complexed with a Peptide from Human Collagen II
1997 • 357 citations
Serological identification of human tumor antigens
1997 • 318 citations
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.
1995 • 310 citations
Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.
1994 • 304 citations
Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.
1998 • 299 citations
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
1996 • 259 citations
Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
1999 • 231 citations
Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.
1992 • 224 citations
MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy
1994 • 98 citations
Defining rules for the peptide-MHC class II interaction
1994 • 87 citations
Sequencing and functional analysis of the genome of Bacillus subtilis strain 168
1996 • 78 citations
HLA Class II Peptide Binding Specificity and Autoimmunity
1997 • 78 citations
Prediction of peptide affinity to HLA DRB1*0401.
1995 • 76 citations
Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
1997 • 57 citations
New methods to predict MHC-binding sequences within protein antigens
1995 • 46 citations
Detection of circulating antibodies against c-myc protein in cancer patient sera
1988 • 40 citations
Progress in the Leishmania genome project
1997 • 21 citations
Parasite Genome Projects and the Trypanosoma cruzi Genome Initiative
1997 • 15 citations
Nomenclature for factors of the HLA system, update January 1998
1998 • 7 citations
Nomenclature for factors of the HLA system, update January 1998
1998 • 2 citations
Techniques to identify the rules governing class II MHC-peptide interaction
1998 • 1 citations